1030377-21-9 Usage
General Description
(R)-2-Hydroxymethyl-piperazine-1-carboxylic acid tert-butyl ester is a chemical compound that is commonly used in the laboratory setting as a precursor for the synthesis of a wide range of drugs, metabolites, and related compounds. It is a tert-butyl ester form of (R)-2-hydroxymethyl-piperazine-1-carboxylic acid, which is a chiral building block that is often used in the pharmaceutical industry for the development of new drugs. The compound has potential application in the synthesis of important pharmaceuticals due to its chiral nature, and it is also used in the preparation of chiral ligands for use in asymmetric synthesis. Additionally, (R)-2-hydroxymethyl-piperazine-1-carboxylic acid tert-butyl ester has been found to have antimicrobial and anticancer properties, making it a valuable compound in drug development and research.
Check Digit Verification of cas no
The CAS Registry Mumber 1030377-21-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,0,3,7 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1030377-21:
(9*1)+(8*0)+(7*3)+(6*0)+(5*3)+(4*7)+(3*7)+(2*2)+(1*1)=99
99 % 10 = 9
So 1030377-21-9 is a valid CAS Registry Number.
1030377-21-9Relevant articles and documents
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
-
Paragraph 1006; 1004, (2018/05/24)
The present invention provides compounds, compositions thereof, and methods of using the same.
Inhibitors of farnesyl-protein transferase
-
, (2008/06/13)
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras. The compounds of formula A are representative of the compounds of the present invention: STR1